Reported Consolidated quarterly numbers for Titan Bio-Tech are:Net Sales at Rs 20.08 crore in March 2020 up 16.31% from Rs. 17.26 crore in March 2019.
Quarterly Net Profit at Rs. 1.92 crore in March 2020 up 192.06% from Rs. 0.66 crore in March 2019.
EBITDA stands at Rs. 3.35 crore in March 2020 up 61.06% from Rs. 2.08 crore in March 2019.
Titan Bio-Tech EPS has increased to Rs. 2.33 in March 2020 from Rs. 0.80 in March 2019.
Titan Bio-Tech shares closed at 72.55 on July 01, 2020 (BSE) and has given 84.84% returns over the last 6 months and 93.47% over the last 12 months.
| Titan Bio-Tech | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'20 | Dec'19 | Mar'19 | | Net Sales/Income from operations | 20.08 | 18.76 | 17.26 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 20.08 | 18.76 | 17.26 | | EXPENDITURE | | Consumption of Raw Materials | 9.54 | 9.66 | 10.44 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.38 | -0.68 | -1.15 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.49 | 3.18 | 3.09 | | Depreciation | 0.45 | 0.46 | 0.40 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 4.27 | 3.42 | 3.05 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 2.72 | 2.72 | 1.43 | | Other Income | 0.18 | 0.11 | 0.25 | | P/L Before Int., Excpt. Items & Tax | 2.90 | 2.82 | 1.68 | | Interest | 0.61 | 0.57 | 0.58 | | P/L Before Exceptional Items & Tax | 2.29 | 2.26 | 1.09 | | Exceptional Items | -- | 0.26 | -- | | P/L Before Tax | 2.29 | 2.52 | 1.09 | | Tax | 0.34 | 0.70 | 0.41 | | P/L After Tax from Ordinary Activities | 1.95 | 1.82 | 0.68 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 1.95 | 1.82 | 0.68 | | Minority Interest | -0.02 | -0.06 | -0.02 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 1.92 | 1.76 | 0.66 | | Equity Share Capital | 8.26 | 8.26 | 8.26 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 2.33 | 2.13 | 0.80 | | Diluted EPS | 2.33 | 2.13 | 0.80 | | EPS After Extra Ordinary | | Basic EPS | 2.33 | 2.13 | 0.80 | | Diluted EPS | 2.33 | 2.13 | 0.80 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
First Published on Jul 2, 2020 09:52 am
